对于外围T细胞淋巴瘤的希斯脱乙酶抑制剂
Ruxandra Irimia1,2, Pier Paolo Piccaluga3,4
1Department of Hematology, "Carol Davila" University of Medicine and Pharmacy, 030167 Bucharest, Romania.
Cancers
|October 16, 2024
概括
基因组脱乙酶抑制剂 (HDACis) 对治疗外围T细胞淋巴瘤 (PTCLs) 有希望,特别是复发或耐药病例. 虽然有效,但HDACis不是一种治疗方法,需要进一步研究组合疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是具有不良预后的侵袭性癌症.
- 基因组脱乙酶抑制剂 (HDACis) 正在成为PTCL治疗的治疗选择.
- 在复发性或耐火性PTCL病例中,HDAC显示出有效性.
研究的目的:
- 审查HDACis在治疗PTCL中的有效性.
- 探索HDACis在PTCL中的作用机制.
- 讨论支持HDACis在PTCL管理中的临床和现实世界的证据.
主要方法:
- 对PTCL的HDACis进行临床试验数据和现实世界的证据的审查.
- 对研究HDAC抗瘤作用的研究进行分析.
- 检查与HDAC的作用机制相关的基因表达特征研究.
主要成果:
- 包括罗米德素和贝利诺斯塔特在内的HDACs在PTCL中表现出有效性,产生持久的反应.
- 通过调节基因表达,HDACs诱导抗瘤效应,导致细胞循环停止和亡.
- 现实世界的数据支持HDACis作为PTCL的有益治疗选择.
结论:
- 对于PTCL患者来说,HDAC代表了一项重要的治疗进展.
- 尽管有积极的结果,但HDACis不能治愈大多数PTCL患者.
- 对新型组合和向药物的进一步研究对于PTCL治疗有必要.
相关概念视频
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...